BD ٣ يونيو ٢٠٢٦ Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics - PR Newswire
BD ٣ يونيو ٢٠٢٦ FDA-cleared blood culture system flags sepsis infections 3 hours faster - Stock Titan
BD ٧ مايو ٢٠٢٦ BD uplifts FY26 revenue outlook based on steady portfolio performance - Medical Device Network
BD ٥ مايو ٢٠٢٦ Analyst Reiterates Buy on Waters as Pharma Demand, BD Synergies and Earnings Outlook Drive Positive Risk-Reward - TipRanks
BD ٢٨ أبريل ٢٠٢٦ BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech - Manufacturing Chemist
BD ٢٧ أبريل ٢٠٢٦ BD, Suttons Creek Partner to Support Pharma & Biotech Companies Developing Combination Products - Contract Pharma
BD ٨ أبريل ٢٠٢٦ BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union - Becton Dickinson
BD ٨ أبريل ٢٠٢٦ FDA clears Onclarity HPV self-collection kit, approves BD Onclarity HPV Assay for cervical cancer screening - Contemporary OB/GYN
BD ٢٤ فبراير ٢٠٢٦ Waters Merger With BD Unit Shifts Focus Toward Diagnostics And Valuation - Yahoo Finance
BD ٩ فبراير ٢٠٢٦ BD Reports First Quarter Fiscal 2026 Financial Results :: Becton, Dickinson and Company (BDX) - Becton Dickinson
BD ٩ فبراير ٢٠٢٦ Waters Completes Combination With BD Biosciences, Diagnostic Solutions Businesses - Contract Pharma
BD ٢٨ يناير ٢٠٢٦ BD, Waters set completion date for $17.5B biosciences and diagnostics merger - MedTech Dive
BD ٢٧ يناير ٢٠٢٦ BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business - Becton Dickinson
BD ١٩ يناير ٢٠٢٦ BD to Highlight Advanced Biologics and Large-Volume Delivery Solutions at Pharmapack 2026 - BD Newsroom
BD ٢٣ يوليو ٢٠٢٥ BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - BD Newsroom